pertussis
Vaccines · 2011–2015
3decisions
3medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| Pertussis vaccine-acellular, combined with diphtheria and tetanus toxoids (DTaP) Prevention of pertussis as an 18-month booster dose in infants. | Jul 2015 | Recommended | none received |
| diphtheria + tetanus + acellular pertussis vaccine Prevention of pertussis as an 18-month booster dose in infants. | Nov 2014 | Recommended | none received |
| Adacel To reduce transmission of pertussis from parents to newborn infants who are too young to have been fully vaccinated against this disease under the infant NIP… | Nov 2011 | Not recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.